AAIC 2025 Abstract
Enhanced anti‐Aß immunotherapies using nanobodies in an AD mouse model
By Alexandre Florent Trotier, Jean David Randrianaly, Amandine Géraudie, Show 5 more authorsAlzheimer's And Prion Diseases
Experiments in animalsInterventions
Abstract
Background: Alzheimer’s disease (AD), the leading cause of dementia, is characterized by amyloid‐beta (Aβ) peptide accumulation, which forms plaques that trigger inflammation, synaptic loss, and neuronal death.
